News & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026

18th annual PEGS Europe, Lisbon, Portugal, November 16-19, 2026

The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics in Tukuba, Japan, November 16-19, 2026

SITC meeting 2026, Phoenix, Arizona, November 4-8

2nd T-Cell Engager for Autoimmune Disease Summit, Boston, October 27-29, 2026

AusBiotech International Conference 2026, Queensland, October 21-23, 2026

Webinar: Enhancing the Translatability of Biologics' Immune-Related Effects and Efficacy Using One Humanized Mouse Model, October 20, 2026

Festival of Biologics, Basel Switzerland, October 13-15, 2026

French BioBeach, San Diego, October 8th, 2026

Lunch & Learn, October 7th, San Diego Biomedical Research Institute: Accelerating Drug Development Through Predictive and Translatable In Vivo Models

BioJapan, Yokohama, October 7-9, 2026

Lunch & Learn, October 6th, Salk Institute for Biological Studies: Accelerating Drug Development Through Predictive and Translatable In Vivo Models

Lunch & Learn, October 5th, La Jolla Institute for Immunology: Accelerating Drug Development Through Predictive and Translatable In Vivo Models

PBSS workshop: Preclinical Development and IND Filing for Antibody-Based Therapeutics: Nuts, Bolts, and Best Practices, San Diego, October 1st, 2026

The 85th Annual Meeting of the Japanese Cancer Association, Kioto, September 24-26, 2026

Webinar: Human-like pattern of expression of Fcγ receptors in humanized mouse model to advance antibody modeling, September 22, 2026

T-Cell Engager Therapeutics Summit 2026, San Diego, June 23-25, 2026

Antibody Engineering & Therapeutics Europe 2026, Basel, Switzerland, May 27-29

BIOLIGN Conference Guangzhou 2026

PEGS Boston, May 11-15, 2026

Lunch & Learn, May 7th: Accelerating Drug Development Through Predictive and Translatable In Vivo Models

genOway Shanghai at Bionnava China 2026

genOway Shanghai at AntibodyChina 2026: The 9th Antibody Therapeutics & ADC Focus Summit

AACR Annual Meeting 2026, San Diego, CAL, April 17-22

Revolutionizing the Prediction of Antibody Therapies in Humans with a Unique Mouse Model

NextGen Biomed 2026, London, UK, March 24-25

10th Tumor Models Summit San Francisco, January 28-29, 2026

genOway Shanghai at ICAR 2026 in Shanghai

genOway Shanghai at BIONNOVA South China Forum 2025

14th Tumour Models Summit London 2025, December 3-4, 2025

genOway Shanghai at the 16th China International Pharmaceutical Expo 2025

7th Myeloid-Directed Summit 2025, November 18-20, 2025

40th SITC meeting 2025, National Harbor, MD, November 5-9

genOway Shanghai at BIONNOVA Beijing Forum 2025

genOway Shanghai at 2025 Future Cell Therapy Executives Summit

genOway Shanghai at Bio Tonacea 2025

5th Fc-Mediated Summit 2025, July 29-31, 2025

genOway Shanghai at BIONNOVA West China Forum 2025

genOway Shanghai - Legal letter - Product name change

AACR Annual Meeting 2025, Chicago, IL, April 25-30

Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025

7th Treg-Directed Therapies Summit 2025, Boston, MA, March 25-27, 2025

NextGen Biomed 2025, London, UK, March 12-14, 2025

genOway signs a three-year contract with a global philanthropic organization supporting the development of infectious diseases therapies

9th Tumor Models San Francisco Summit 2025, January 29-30, 2025

13th Tumour Models London Summit 2024, December 4-5, 2024

39th SITC meeting 2024, Houston, TX, November 6-10

ESMO (European Society For Medical Oncology) 2024, Barcelona, Spain, September 13-17, 2024

genOway Shanghai at the Chinese Biopharmaceutical Association meeting 2024

5th Annual STING & TLR-Targeted Therapies Summit, San Diego, CA, June 19-20, 2024